Sale!

Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test

Original price was: $550.Current price is: $376.

-32%

The Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test is a critical diagnostic tool for managing drug-resistant tuberculosis. This advanced test evaluates Mycobacterium tuberculosis susceptibility to 10 essential second-line antitubercular medications using automated fluorescent technology. It provides vital information for physicians treating multidrug-resistant TB cases, helping guide effective treatment strategies when first-line drugs fail. The test measures resistance patterns to drugs including Amikacin, Kanamycin, Capreomycin, and fluoroquinolones. Available for $376 USD, this comprehensive panel delivers results within 21 days and requires no special patient preparation. Early detection of drug resistance significantly improves treatment outcomes and reduces transmission risks.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test

Comprehensive Tuberculosis Drug Sensitivity Testing

The Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test represents a breakthrough in tuberculosis management, specifically designed to combat the growing threat of multidrug-resistant tuberculosis (MDR-TB). This sophisticated diagnostic tool utilizes automated fluorescent technology to rapidly assess Mycobacterium tuberculosis complex susceptibility to 10 critical second-line antitubercular medications. When first-line TB treatments prove ineffective, this panel becomes essential for developing successful treatment regimens that can overcome drug resistance and save lives.

What This Test Measures and Detects

This comprehensive panel evaluates bacterial susceptibility to the following 10 second-line antitubercular drugs:

  • Amikacin – Aminoglycoside antibiotic
  • Kanamycin – Aminoglycoside antibiotic
  • Capreomycin – Polypeptide antibiotic
  • Clofazimine – Riminophenazine antibiotic
  • Ethionamide – Thioamide antibiotic
  • Ofloxacin – Fluoroquinolone antibiotic
  • Levofloxacin – Fluoroquinolone antibiotic
  • Moxifloxacin – Fluoroquinolone antibiotic
  • PAS (Para-aminosalicylic acid)
  • Cycloserine – Broad-spectrum antibiotic

The test determines the minimum inhibitory concentration (MIC) for each drug, providing precise data about which medications will effectively combat the specific TB strain.

Who Should Consider This Test

Clinical Indications and Symptoms

This advanced testing is crucial for patients experiencing:

  • Persistent TB symptoms despite first-line treatment
  • Treatment failure with standard TB medications
  • Known exposure to drug-resistant TB strains
  • Recurrent tuberculosis infections
  • Immune-compromised status with suspected TB
  • Previous history of incomplete TB treatment
  • Residence in areas with high MDR-TB prevalence

Benefits of Taking This Test

Choosing the Cultured AFB Antitubercular DST Rapid Panel offers numerous advantages:

  • Personalized Treatment Planning: Enables physicians to create targeted therapy regimens based on actual drug susceptibility patterns
  • Reduced Treatment Duration: Helps avoid ineffective medications, potentially shortening overall treatment time
  • Cost-Effective Care: Prevents spending on drugs that won’t work, optimizing healthcare resources
  • Improved Outcomes: Significantly increases treatment success rates for drug-resistant TB
  • Public Health Protection: Helps contain the spread of drug-resistant strains through effective treatment
  • Comprehensive Coverage: Tests 10 essential second-line drugs in a single panel

Understanding Your Test Results

Interpretation Guidance

Your test results will provide detailed information about your TB strain’s susceptibility to each of the 10 second-line drugs:

  • Susceptible: The drug is likely to be effective against your TB strain
  • Resistant: The drug is unlikely to work, and alternative medications should be considered
  • Intermediate: The drug may work at higher doses or in combination with other medications

Your physician will use these results to design a customized treatment regimen that specifically targets your drug-resistant TB strain. The comprehensive nature of this 10-drug panel ensures multiple therapeutic options are available, even with complex resistance patterns.

Test Pricing and Details

Test Component Regular Price Discount Price
Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test $550 USD $376 USD

Additional Test Information

  • Turnaround Time: Sample accepted daily by 3:30 PM; Results in 21 days
  • Sample Type: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw-capped container
  • Shipping: Ship refrigerated in sealed plastic bag
  • Preparation: No special preparation required
  • Methodology: Automated Fluorescent Technology

Nationwide Testing Availability

We have diagnostic branches conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible tuberculosis testing for patients throughout the country.

Book Your Test Today

Don’t let drug-resistant tuberculosis compromise your health. Our Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test provides the critical information needed to combat MDR-TB effectively. Take control of your tuberculosis treatment with comprehensive drug sensitivity testing.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our tuberculosis specialists. Early detection of drug resistance can make all the difference in your treatment success.